Thalidomide Analog class drugs

2 results
Zydus Lifesciences Limited
Celgene Corporation
Usage: POMALYST is indicated for adult patients with multiple myeloma who have undergone at least two prior therapies, including lenalidomide and a proteasome inhibitor, demonstrating disease progression. It is also indicated for treating AIDS-related Kaposi sarcoma after HAART failure and Kaposi sarcoma in HIV-negative adults.